Clinical Trial Update: DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DaunoXome plus cytarabine against daunorubicin plus cytarabine in elderly patients with acute myeloid leukemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DaunoXome (daunorubicin liposome)
• Daunorubicin (daunorubicin)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: AML, Elderly | Phase 3 | Status: COMPLETED